PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer

Clinical Trial ID NCT00005916

Rank	Title	Journal	Year	PubWeight™‹?›
1	Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.	Clin Cancer Res	2005	3.57
2	Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.	Clin Cancer Res	2008	1.81
3	Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant.	Clin Cancer Res	2008	1.56
4	Technologies for enhanced efficacy of DNA vaccines.	Expert Rev Vaccines	2012	1.44
5	A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients.	Clin Cancer Res	2010	1.30
6	Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer.	Cancer Immunol Res	2013	1.16
7	Poxviral-based vaccine elicits immunologic responses in prostate cancer patients.	Oncoimmunology	2014	0.81
8	Oncolytic virotherapy for urological cancers.	Nat Rev Urol	2016	0.76